Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice | |
Fan, Yunxia[1]; Du, Liwu[2]; Fu, Qun[3]; Zhou, Zhiqiang[4]; Zhang, Jingyu[5]; Li, Guomin[6]; Wu, Jing[7] | |
刊名 | FRONTIERS IN CELLULAR NEUROSCIENCE |
2018 | |
卷号 | 12页码:426 |
关键词 | NLRP3 neuroinflammation pyroptosis cognitive impairment general anesthesia aging |
ISSN号 | 1662-5102 |
DOI | http://dx.doi.org/10.3389/fncel.2018.00426 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000450546400001 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5330309 |
专题 | 江苏大学 |
作者单位 | 1.[1]Jiangsu Univ, Jintan Hosp, Dept Anesthesiol, Changzhou, Peoples R China. 2.[2]Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Anesthesiol, Nanjing Branch, Nanjing, Jiangsu, Peoples R China. 3.[3]Nanjing Med Univ, Jinling Clin Med Coll, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China. 4.[4]Nanjing Med Univ, Jinling Clin Med Coll, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Jintan Hosp, Dept Anesthesiol, Changzhou, Peoples R China. 6.[6]Jiangsu Univ, Jintan Hosp, Dept Anesthesiol, Changzhou, Peoples R China. 7.[7]Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Fan, Yunxia[1],Du, Liwu[2],Fu, Qun[3],et al. Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice[J]. FRONTIERS IN CELLULAR NEUROSCIENCE,2018,12:426. |
APA | Fan, Yunxia[1].,Du, Liwu[2].,Fu, Qun[3].,Zhou, Zhiqiang[4].,Zhang, Jingyu[5].,...&Wu, Jing[7].(2018).Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice.FRONTIERS IN CELLULAR NEUROSCIENCE,12,426. |
MLA | Fan, Yunxia[1],et al."Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice".FRONTIERS IN CELLULAR NEUROSCIENCE 12(2018):426. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论